Cholesterol-Lowering Drug Boosts Bone Repair in Max-Planck Institute for Molecular Genetics Study
ScienceDaily — Lovastatin, a drug used to lower cholesterol and help prevent cardiovascular disease, has been shown to improve bone healing in an animal model of neurofibromatosis type 1 (NF1). The research, reported today in the open access journal BMC Medicine, will be of great interest to NF1 patients and their physicians.